Expertise in
5
conditions
Expertise in
5
conditions
1301 Medical Ctr Dr, 
Nashville, TN 

Overview

Debra Friedman is a Pediatric Hematologist Oncology provider in Nashville, Tennessee. Dr. Friedman is highly rated in 5 conditions, according to our data. Her top areas of expertise are Hodgkin Lymphoma, Retinoblastoma, Febrile Neutropenia, and Infantile Neutropenia.

Her clinical research consists of co-authoring 147 peer reviewed articles and participating in 22 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in WA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

VANDERBILT UNIVERSITY MEDICAL CENTER
1301 Medical Ctr Dr, Nashville, TN 37232

Additional Areas of Focus

Dr. Friedman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


22 Clinical Trials

A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma
View 21 Less Clinical Trials

147 Total Publications

NCCN Guidelines® Insights: Survivorship, Version 2.2025.
Similar Doctors
Expertise in
21
conditions
Pediatric Hematology Oncology
Expertise in
21
conditions
Pediatric Hematology Oncology

Womens And Childrens Specialists, LLC

330 23rd Ave N, Suite 100, 
Nashville, TN 
 (1.0 miles away)
Languages Spoken:
English

Haydar Frangoul is a Pediatric Hematologist Oncology provider in Nashville, Tennessee. Dr. Frangoul is highly rated in 21 conditions, according to our data. His top areas of expertise are Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
5
conditions
Pediatric Hematology Oncology
Expertise in
5
conditions
Pediatric Hematology Oncology
1035 14th Ave N, 
Nashville, TN 
 (2.0 miles away)
Languages Spoken:
English
Offers Telehealth

Michael Debaun is a Pediatric Hematologist Oncology provider in Nashville, Tennessee. Dr. Debaun is highly rated in 5 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.

Expertise in
7
conditions
Pediatric Hematology Oncology
Expertise in
7
conditions
Pediatric Hematology Oncology

Verdi Oncology Tennessee PC

335 24th Ave N, Suite 200, 
Nashville, TN 
 (0.9 miles away)
Languages Spoken:
English
Offers Telehealth

Vivek Subbiah is a Pediatric Hematologist Oncology provider in Nashville, Tennessee. Dr. Subbiah is highly rated in 7 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Desmoplastic Small Round Cell Tumor, Ewing Sarcoma, and Osteosarcoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Friedman's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile